Detailed information for compound 1854631

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 451.493 | Formula: C24H26FN5O3
  • H donors: 3 H acceptors: 2 LogP: 3.92 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: CNC(=O)c1ccccc1Nc1cc(ncc1F)Nc1ccc(cc1OC)N1CCOCC1
  • InChi: 1S/C24H26FN5O3/c1-26-24(31)17-5-3-4-6-19(17)28-21-14-23(27-15-18(21)25)29-20-8-7-16(13-22(20)32-2)30-9-11-33-12-10-30/h3-8,13-15H,9-12H2,1-2H3,(H,26,31)(H2,27,28,29)
  • InChiKey: UPOMRTKHZCWMBW-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens mitogen-activated protein kinase 8 Starlite/ChEMBL No references
Homo sapiens mitogen-activated protein kinase 10 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis c Jun NH2 terminal kinase Get druggable targets OG5_129677 All targets in OG5_129677
Echinococcus granulosus c-Jun N-terminal kinases Get druggable targets OG5_129677 All targets in OG5_129677
Schistosoma japonicum ko:K04440 c-Jun N-terminal kinase, putative Get druggable targets OG5_129677 All targets in OG5_129677
Schistosoma japonicum IPR000164,Histone H3;IPR009072,Histone-fold,domain-containing Get druggable targets OG5_129677 All targets in OG5_129677
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129677 All targets in OG5_129677
Loa Loa (eye worm) CMGC/MAPK/JNK protein kinase Get druggable targets OG5_129677 All targets in OG5_129677
Brugia malayi Stress-activated protein kinase jnk-1 Get druggable targets OG5_129677 All targets in OG5_129677
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis c Jun NH2 terminal kinase 0.0558 1 1
Trypanosoma cruzi Rab-like 5, small G protein 0.0023 0 0.5
Brugia malayi Protein kinase domain containing protein 0.054 0.9668 0.9668
Echinococcus multilocularis leucine rich repeat serine:threonine protein 0.054 0.9668 0.9668
Schistosoma mansoni serine/threonine protein kinase 0.0558 1 1
Leishmania major hypothetical protein, conserved 0.0023 0 0.5
Trypanosoma brucei Rab-like 5, small G protein 0.0023 0 0.5
Trichomonas vaginalis GTP binding protein rare7l, putative 0.0023 0 0.5
Plasmodium falciparum ras-related protein Rab-5A 0.0023 0 0.5
Entamoeba histolytica hypothetical protein 0.0023 0 0.5
Trichomonas vaginalis hypothetical protein 0.0023 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0023 0 0.5
Entamoeba histolytica hypothetical protein 0.0023 0 0.5
Plasmodium vivax ras-related protein Rab-5A, putative 0.0023 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0023 0 0.5
Echinococcus granulosus leucine rich repeat serine:threonine protein 0.0544 0.9736 0.9736
Leishmania major hypothetical protein, conserved 0.0023 0 0.5
Loa Loa (eye worm) TKL/LRRK protein kinase 0.054 0.9668 0.9668
Onchocerca volvulus 0.0023 0 0.5
Loa Loa (eye worm) CMGC/MAPK/JNK protein kinase 0.0558 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0023 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0023 0 0.5
Echinococcus granulosus c-Jun N-terminal kinases 0.0558 1 1
Onchocerca volvulus Mitochondrial Rho GTPase homolog 0.0023 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 320 nM Inhibition of JNK3 (unknown origin) using biotinylated ATF2 by HTRF method ChEMBL. No reference
IC50 (binding) = 590 nM Inhibition of JNK2 (unknown origin) using biotinylated ATF2 by HTRF method ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.